Table 2

 Cancer risks for sites other than breast and ovary in BRCA2 mutation carriers

ICD codeLocationObsExpRR95% CIPa (n)
See Methods section for estimating RR. Obs, observed, exp, expected.
All199199.910.9 to 1.1 85
140–149Buccal cavity and pharynx63.62.40.9 to 5.34
141Tongue10.62.40.03 to 13.11
142Salivary glands10.44.60.1 to 25.41
143–145Mouth00.9
146–149Pharynx41.07.32.0 to 18.62
150–159Digestive system6050.11.51.1 to 1.925
150Oesophagus12.0
151Stomach1312.11.20.6 to 2.02
152Small intestine10.53.70.05 to 20.6
153Colon2016.51.50.9 to 2.311
154Rectum310.82
153–154Colon/rectum2327.20.70.4 to 1.013
155Liver50.910.93.5 to 25.42
156Gallbladder and extrahepatic bile duct12.81
157Pancreas144.45.93.2 to 10.07
160–165Respiratory system3544.30.50.4 to 0.813
160Nasal cavaties00.4
161Larynx32.71.20.2 to 3.62
162Lung3040.40.40.3 to 0.69
163Pleura/mesothelium00.6
170Bones30.414.42.9 to 42.11
171Connective tissues11.10.80.01 to 4.61
172Melanoma23.50.10.01 to 0.21
179–189Urogenital system4340.51.20.8 to 1.620
180Cervix uteri12.51
182Corpus uteri64.41.80.7 to 3.93
185Prostate gland2413.62.51.6 to 3.87
186Testis00.8
187Penis00.3
188Bladder98.41.20.5 to 2.36
189Kidney35.20.10.02 to 0.23
191Brain52.23.91.2 to 9.01
192Thyroid gland10.91.10.01 to 6.0
200–208Leukaemia and lymphoma812.40.20.1 to 0.45
200Non-Hodgkin’s disease34.90.20.03 to 0.42
201Hodgkin’s disease01.0
204–208Leukaemia54.11.50.5 to 3.53